title: Immunotherapy for bladder cancer: rediscovering an old friend.
authors.affiliation: Department of Medical Oncology, Guy's Hospital, London, UK.|Sarah Cannon Research Institute UK, London, UK.
authors.forename: Mark
authors.identifier: http://orcid.org/0000-0002-4242-1300
authors.initials: M
authors.lastname: Voskoboynik
authors.affiliation: Department of Medical Oncology, Guy's Hospital, London, UK.
authors.forename: Sarah
authors.initials: S
authors.lastname: Rudman
authors.affiliation: Sarah Cannon Research Institute UK, London, UK.|University College London, London, UK.
authors.forename: Hendrik-Tobias
authors.initials: HT
authors.lastname: Arkenau
authors.affiliation: Department of Medical Oncology, Guy's Hospital, London, UK.
authors.forename: Simon
authors.initials: S
authors.lastname: Hughes
authors.affiliation: Department of Medical Oncology, Guy's Hospital, London, UK.|Sarah Cannon Research Institute UK, London, UK.
authors.forename: Simon
authors.initials: S
authors.lastname: Chowdhury
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D060890:B7-H1 Antigen / Q000037:antagonists & inhibitors; D001500:BCG Vaccine / Q000627:therapeutic use; D060908:CTLA-4 Antigen / Q000037:antagonists & inhibitors; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D007167:Immunotherapy; D061026:Programmed Cell Death 1 Receptor / Q000037:antagonists & inhibitors; D001749:Urinary Bladder Neoplasms / Q000628:therapy*
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D060890:B7-H1 Antigen; D001500:BCG Vaccine; D060908:CTLA-4 Antigen; D007155:Immunologic Factors; C105992:PDCD1 protein, human; D061026:Programmed Cell Death 1 Receptor